New IVF drug combo shows promise for better embryos
NCT ID NCT05873725
First seen Jan 04, 2026 · Last updated May 17, 2026 · Updated 21 times
Summary
This study tested a high dose of the fertility drug follitropin delta combined with hCG in 118 women undergoing IVF. The goal was to see if it could increase the number of good-quality embryos. Participants were women aged 18 to 42 with regular cycles. The study was completed and looked back at past data.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinique Ovo
Montreal, Quebec, H4P 2S4, Canada
Conditions
Explore the condition pages connected to this study.